1-(3-甲氧苯基)-1H-吡咯-2,5-二酮 | 3007-23-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯啉
• 中文名称: 1-(3-甲氧苯基)-1H-吡咯-2,5-二酮
• 中文别名: 1-(3-甲氧基苯基)-2,5-二氢-1H-吡咯-2,5-二酮
• 英文名称: N-(3-methoxyphenyl)maleimide
• 英文别名: 1-(3-methoxyphenyl)-1H-pyrrole-2,5-dione；N-(m-Methoxyphenyl)-maleinimid；1-(3-methoxyphenyl)pyrrole-2,5-dione
• CAS: 3007-23-6
• 化学式: C₁₁H₉NO₃
• mdl: MFCD00090444
• 分子量: 203.197
• InChiKey: UNCUTNPWBZKJHD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R20/21/22,R36/37/38
• 海关编码：
  2925190090

SDS

Name:	1-(3-Methoxyphenyl)-2 5-dihydro-1h-pyrrole-2 5-dione 97% Material Safety Data Sheet
Synonym:
CAS:	3007-23-6

Section 1 - Chemical Product MSDS Name:1-(3-Methoxyphenyl)-2 5-dihydro-1h-pyrrole-2 5-dione 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
3007-23-6	1-(3-Methoxyphenyl)-2,5-dihydro-1H-pyr	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 3007-23-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 62 - 66 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H9NO3
Molecular Weight: 203

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 3007-23-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(3-Methoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 3007-23-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 3007-23-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 3007-23-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(3-甲氧苯基)-1H-吡咯-2,5-二酮 在 氯磺酸 作用下， 以 乙腈 为溶剂， 反应 4.0h， 生成 2-(2,5-Dioxo-2,5-dihydro-pyrrol-1-yl)-N,N-diethyl-4-methoxy-benzenesulfonamide
  参考文献：
  名称：

  Tome, Augusto C.; Cavaleiro, Jose A. S.; Domingues, Fernando M. J., Phosphorus, Sulfur and Silicon and the Related Elements, 1993, vol. 79, # 1,4, p. 187 - 194

  摘要：

  DOI：
• 作为产物：
  描述：

  N-(间甲氧基苯基)马来酰胺 在 sodium acetate 、 乙酸酐 作用下， 反应 2.0h， 生成 1-(3-甲氧苯基)-1H-吡咯-2,5-二酮
  参考文献：
  名称：

  一系列N-烷基，N-芳基和N-烷基苯基-1,4-吡咯烷二酮和相关化合物的抗真菌，细胞毒性和SAR研究

  摘要：

  报道了67种马来酰亚胺及其衍生物作为抗真菌剂的合成，体外评估和SAR研究。由理论计算支持的详细SAR研究使我们确定：完整的马来酰亚胺环似乎对于强的抗真菌活性是必需的，与位置2和3上的取代基不同。然后是2,3二氯和2-甲基取代的马来酰亚胺。它们都是杀真菌剂，而不是抑真菌剂，增强了其抗真菌活性的重要性。2,3-二甲基和2,3-二苯基-马来酰亚胺具有边际活性或无效活性。N中存在灵活的连接链-苯基烷基马来酰亚胺似乎不是抗真菌活性所必需的，尽管其长度显示出与抗真菌行为的相关性，显示出烷基链为n  = 3和n  = 4的马来酰亚胺是大多数真菌中最佳的抗真菌活性。苯环上的不同取代基对活性没有明显的影响。化学势性质以及能量的值不能充分区分活性化合物和非活性化合物。尽管如此，发现尽管log  P单凭其强度不足以正确预测其抗真菌活性，对同一亚型化合物的抗真菌活性值的比较表明，抗真菌活性随亲脂性的增加而增强。另

  DOI：

  10.1016/j.bmc.2011.03.038

文献信息

• [EN] [18F]MALEIMIDE-BASED GLYCOGEN SYNTHASE KINASE-3BETA LIGANDS FOR POSITRON EMISSION TOMOGRAPHY IMAGING AND RADIOSYNTHESIS METHOD<br/>[FR] LIGANDS DE GLYCOGÈNE SYNTHASE KINASE-3β À BASE DE [18F]MALÉIMIDE POUR IMAGERIE PAR TOMOGRAPHIE PAR ÉMISSION DE POSITRONS ET PROCÉDÉ DE RADIOSYNTHÈSE
  申请人：UNIV NEW YORK STATE RES FOUND

  公开号：WO2018132636A1

  公开（公告）日：2018-07-19

  The present invention provides a compound having the structure: (Formula I), and a method of inhibiting Glycogen synthase kinase-3 β (GSK-3β) in a subject comprising administering to the subject said compound, so as to thereby inhibit the GSK-3β in the subject.

  本发明提供了一种具有结构的化合物：（式I），以及一种抑制糖原合成酶激酶-3β（GSK-3β）的方法，包括向受试者施用所述化合物，从而抑制受试者中的GSK-3β。
• Isatin <i>N</i>,<i>N</i>′-Cyclic Azomethine Imine 1,3-Dipole and Abnormal [3 + 2]-Cycloaddition with Maleimide in the Presence of 1,4-Diazabicyclo[2.2.2]octane
  作者：Xiao Wang、Peng Yang、Yong Zhang、Chao-Zhe Tang、Fang Tian、Lin Peng、Li-Xin Wang

  DOI：10.1021/acs.orglett.6b03815

  日期：2017.2.3

  A new isatin N,N′-cyclic azomethine imine synthon was devised, and an unexpected abnormal [3 + 2]-cycloaddition with maleimide catalyzed by 1,4-diazabicyclo[2.2.2]octane (DABCO) has been disclosed. A variety of tricyclic spiropyrrolidine oxindoles bearing a dinitrogen heterocycle and succinimide scaffold were obtained in excellent yields (up to 96%) and diastereoselectivities (up to 97:3) under mild

  设计了一种新的Isatin N，N'-环甲亚胺亚胺合子，并公开了1,4-二氮杂双环[2.2.2]辛烷（DABCO）催化的马来酰亚胺意外异常[3 + 2]-环加成反应。在温和条件下，以优异的收率（高达96％）和非对映选择性（高达97：3）获得了多种带有二氮杂环和琥珀酰亚胺支架的三环螺吡咯烷恶唑。
• Access to Indoles via Diels-Alder Reactions of 5-Methylthio-2-vinylpyrroles with Maleimides
  作者：Wayland E. Noland、Nicholas P. Lanzatella、Rozalin R. Dickson、Mary E. Messner、Huy H. Nguyen

  DOI：10.1002/jhet.1571

  日期：2013.7

  Diels–Alder reactions of 5‐methylthio‐2‐vinyl‐1H‐pyrroles with maleimides followed by isomerization gave tetrahydroindoles in moderate to good yield. Aromatization using activated MnO2 in refluxing toluene gave the corresponding 2‐methylthioindoles in good yields, and demethylthioation using Raney nickel gave the 2‐H indoles in excellent yields. The protection of the adducts produced aromatization

  5-甲硫基-2-乙烯基-1 H-吡咯与马来酰亚胺的Diels-Alder反应，然后异构化，得到中等产率至中等产率的四氢吲哚。使用活化的MnO 2进行芳香化在回流条件下，甲苯得到高收率的相应的2-甲基硫吲哚，用阮内镍进行脱甲基硫代反应得到的2-H吲哚的收率很高。加合物的保护以提高的收率产生芳构化，证明了甲硫基作为吡咯的保护基的有效性。但是，在Diels-Alder反应中，显示5-甲硫基-2-乙烯基吡咯的效率比2-乙烯基吡咯略低，表明该保护基的失活程度超过了预期。这种通往吲哚的途径提供了高度收敛性和易于获得的易于纯化的起始原料。已证明双甲硫基乙烯基吡咯具有作为高活化Diels-Alder二烯的潜力。
• Synthesis and in Vitro Evaluation of N-Substituted Maleimide Derivatives as Selective Monoglyceride Lipase Inhibitors
  作者：Nicolas Matuszak、Giulio G. Muccioli、Geoffray Labar、Didier M. Lambert

  DOI：10.1021/jm900461w

  日期：2009.12.10

  action is quickly terminated via enzymatic hydrolysis catalyzed by monoglyceride lipase (MGL). Regulating its endogenous level could offer therapeutic opportunities; however, few selective MGL inhibitors have been described so far. Here, we describe the synthesis of N-substituted maleimides and their pharmacological evaluation on the recombinant human fatty acid amide hydrolase (FAAH) and on the purified

  内源性大麻素2-花生四烯酸甘油酯（2-AG）在许多生理过程中起着重要作用，其作用通过甘油单酯脂肪酶（MGL）催化的酶促水解迅速终止。调节其内源水平可以提供治疗机会；然而，到目前为止，几乎没有描述选择性的MGL抑制剂。在这里，我们描述了N-取代的马来酰亚胺的合成及其对重组人脂肪酸酰胺水解酶（FAAH）和纯化人MGL的药理评价。先前已经描述了一些N-芳基马来酰亚胺（萨里奥（SM）；萨洛（OM）；Nevalainen，T .；Poso，A。莱蒂宁（JT）；贾文恩（T. Jarvinen）Niemi，R.大鼠小脑膜中2-花生四烯酸甘油水解酶中巯基敏感位点的表征。化学 生物学 2005年，12，649-656），为MGL抑制剂，以及沿着这些线路，我们提出一组新的马来酰亚胺衍生物的那显示出低微摩尔的IC 50和朝向MGL VS FAAH高选择性。然后，研究了结构活性关系，例如，1-biphenyl-4
• Synthesis and antimicrobial activities of N-substituted imides
  作者：Frederic Zentz、Alain Valla、Regis Le Guillou、Roger Labia、Anne-Gabrielle Mathot、Danielle Sirot

  DOI：10.1016/s0014-827x(02)01217-x

  日期：2002.4

  toluene. Most of N-substituted maleimides showed an interesting antimicrobial activity towards bacteria from the ATCC collection (Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) but the MIC values for P. aeruginosa were always high (128 microg/ml). The imides with alkyl substituents showed higher activities than aromatic

  在我们关于新型抗菌剂的研究计划领域中，合成了一系列N-取代的酰亚胺。这些化合物是通过将酰胺基酸在乙酸酐/乙酸钠或六甲基二硅氮烷/溴化锌中的羟基芳族衍生物环化而获得的。羟基烷基马来酰亚胺是通过将相应的氨基醇与马来酸酐在沸腾的甲苯中缩合而直接制备的。大多数N-取代的马来酰亚胺对来自ATCC集合的细菌（金黄色葡萄球菌ATCC 25923，粪肠球菌ATCC 29212，大肠杆菌ATCC 25922和铜绿假单胞菌ATCC 27853）显示出有趣的抗菌活性，但铜绿假单胞菌的MIC值始终很高（ 128微克/毫升）。具有烷基取代基的酰亚胺显示出比​​MIC值在8-32 microg / ml范围内的芳族类似物更高的活性。相比之下，琥珀酰亚胺几乎没有活性。